In accordance with the ACCME Standards for Integrity
and Independence, the Association of Diabetes Care & Education Specialists
(ADCES) requires anyone in a position to affect or control continuing education
content (e.g., authors, presenters, and program planners) to disclose all
financial relationships with ineligible companies. It is the responsibility of
ADCES to mitigate and disclose all relevant conflicts of interest. Disclosure
of a relationship is not intended to suggest or condone bias in any
presentation but is made to provide participants with information that might be
of potential importance to their evaluation of the presentation.
Relevant disclosures (or lack thereof)
among educational activity planners and faculty are as follows:
Gretchen Benson, RDN, CDCES – No conflicts of interest
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP – Speakers Bureau: Dexcom, Insulet, Medtronic, Abbott, Novo Nordisk, Bayer, Xeris Pharmaceuticals; Consultant: Lilly, Sanofi, Tempramed, DiabetesWise, DiaTribe
Jodi Lavin-Tompkins, MSN, RN, CDCES, BC-ADM – Stock: Gilead Sciences, Regeneron Pharma
The approval of this educational
offering by the ADCES does not imply endorsement of specific therapies,
treatments, or products discussed in the presentations.
Disclosure of Relevant Financial
Relationships and Mechanism to Identify and Resolved Conflicts of
All identified relevant conflicts of interest have been mitigated.